Dairy Cow Micro-View focuses on Anmuda's APT technology: precisely solving the mastitis problem and empowering pastures to increase efficiency and profitability.
Recently, the authoritative industry media outlet *Dairy Cow Micro Insights *published a special article on February 4, 2026, titled "Anmuda APT Shockwave Treatment for Mastitis: Saving 615 Yuan Per Cow, Thousands of Cows Earning an Extra 86,300 Yuan Annually," providing an in depth analysis of the innovative breakthroughs and core value of Anmuda APT shockwave technology in the treatment of mstitis in dairy cows. The article comprehensively showcases the practical effects of this technology on reducing costs and increasing efficiency for dairy pastures, attacting widespread attention within the industry.
Currently, the dairy market faces the dual pressures of inverted raw milk prices and rising breeding costs. Against this backdrop, mastitis, as the most common and costly disease in dairy farming, has become a key bottleneck restricting the profitability of dairy pastures.The clinical incidence rate is 0.6%-2%, with an average loss of 800-1000 yuan percase. The entire industry loses 3.6 billion yuan in profits
annually due to mastitis. "Less medication, no milk abandonment, and quick cure" has become the core demand for the survival and development of dairy pastures in 2026.
The "Dairy Cow Micro-View" feature article highlights the differentiated
advantages of Anmuda's APT shockwave technology, which breaks through the limitations of traditional antibiotic treatment and achieves highly effective treatment of mastitis through physical therapy. This technology uses "pneumatic ballistic shockwaves" to "absorb, flush, and loosen" inflammatory emboli within the mammary ducts, while simultaneously activating local vascular endothelial growth factor, clearing microcirculation, and combining physical unblocking with biological self-healing. The entire process is antibiotic-free, hormone-free, and involves no
milk discarding, truly achieving "treatment without affecting milk production and cure without drug residue."
The article uses precise data to demonstrate the value of the technology: the comprehensive cost of traditional conventional drug treatment for mastitis in a dairy cow is approximately 680-1000 yuan, while the Anmuda APT shockwave
technology costs only 65 yuan for the entire treatment course, directly saving 615yuan per cow. Taking a pasture with 1,000 adult cows as a model, and calculating based on a clinical incidence rate of 0.6%, approximately 80 cases of mastitis occur annually, resulting in cost savings of nearly 50,000 yuan in treatment alone. Adding the additional revenue from "no abandoned milk"—80 sick cows × 30kg daily
milk production × 3.03 yuan/kg raw milk price × 5-day treatment cycle—an
additional revenue of approximately 36,300 yuan can be generated. In total, a farm with 1,000 cows can generate an additional 86,300 yuan in profit annually, opening up a new profit growth point for the pasture.
In addition to its core cost advantages, the article also disclosed the measuredeffectiveness of Anmuda's APT shockwave technology: verified by more than 20 ranches, the technology has a cure rate of 94.1% for grade 1 clinical mastitis and 82.5% for grade 2 mastitis, both higher than the 57%-73% of traditional drug treatment; at the same time, it can reduce the amount of antibiotics used by half, which not only reduces drug costs but also avoids the risk of drug-resistant bacteria
growth, in line with the industry's trend of antibiotic reduction and antibiotic-free
development. The article cites firsthand feedback from a ranch manager in Dengkou, Inner Mongolia: "After introducing the Anmuda APT shockwave equipment, the cost of treating mastitis has dropped significantly, even more cost effective
than to a better feed formula." This genuine assessment vividly demonstrates the practical value of the technology in real world farming scenarios. To further lower
the barriers to entry for ranches, Amuda also offers a bundled service of "equipment + training + data followup," and introduces flexible payment methods such as equipment leasing and rent-to-own, effectively alleviating cash flow pressure
on ranches and allowing more ranches to easily enjoy the benefits of technology.
This special report in "Dairy Cow Micro View" not only highly recognizes Anmuda's APT shockwave technology but also represents the industry's positive response to innovation in mastitis treatment. Faced with the industry's current situation of low milk prices, high costs, and strict antibiotic reduction, Anmuda has consistently focused on technological innovation, addressing the actual needs of pastures, andcontinuously optimizing its products and services. Currently, this technology has been implemented in multiple dairy farming groups in Ningxia, Hebei, Heilongjiang, Inner Mongolia, and other regions, with a cumulative cure rate exceeding 10,000 head.
In the future, Amuda will continue to focus on the field of healthy dairy farming, leveraging core technologies such as APT shockwave therapy to provide pastures with more efficient, economical, and environmentally friendly mastitis solutions. This will help farms reduce costs, increase efficiency, improve profitability, and promote the high-quality and sustainable development of the dairy industry.
For more information on Anmuda's APT shockwave technology, please contact official channels for professional consultation and services.